133 related articles for article (PubMed ID: 12900068)
1. Suboptimal performance on neuropsychological tests in patients with suspected chronic toxic encephalopathy.
van Hout MS; Schmand B; Wekking EM; Hageman G; Deelman BG
Neurotoxicology; 2003 Aug; 24(4-5):547-51. PubMed ID: 12900068
[TBL] [Abstract][Full Text] [Related]
2. Validity of a computer-assisted neurobehavioral test battery in toxicant encephalopathy.
Proctor SP; Letz R; White RF
Neurotoxicology; 2000 Oct; 21(5):703-14. PubMed ID: 11130274
[TBL] [Abstract][Full Text] [Related]
3. Cognitive functioning in patients with suspected chronic toxic encephalopathy: evidence for neuropsychological disturbances after controlling for insufficient effort.
van Hout MS; Schmand B; Wekking EM; Deelman BG
J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):296-303. PubMed ID: 16484635
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the French version of EUROQUEST: a questionnaire for neurotoxic symptoms.
Rouch I; Wild P; Fontana JM; Chouaniere D
Neurotoxicology; 2003 Aug; 24(4-5):541-6. PubMed ID: 12900067
[TBL] [Abstract][Full Text] [Related]
5. Influence of personality traits on neuropsychological test performance in toxic encephalopathy cases and healthy referent subjects.
Persson R; Osterberg K; Karlson B; Orbaek P
Neurotoxicology; 2000 Oct; 21(5):667-75. PubMed ID: 11130270
[TBL] [Abstract][Full Text] [Related]
6. [Solvent-induced chronic encephalopathy; the 'solvent team' project].
van der Hoek JA; Verberk MM; van der Laan G; Hageman G
Ned Tijdschr Geneeskd; 2001 Feb; 145(6):256-60. PubMed ID: 11236371
[TBL] [Abstract][Full Text] [Related]
7. Euroquest: the validity of a new symptom questionnaire.
Karlson B; Osterberg K; Orbaek P
Neurotoxicology; 2000 Oct; 21(5):783-9. PubMed ID: 11130283
[TBL] [Abstract][Full Text] [Related]
8. Abbreviated form of the test of memory malingering.
Horner MD; Bedwell JS; Duong A
Int J Neurosci; 2006 Oct; 116(10):1181-6. PubMed ID: 16923686
[TBL] [Abstract][Full Text] [Related]
9. Organic solvent induced chronic toxic encephalopathy: extent of recovery, and associated factors, following cessation of exposure.
Dryson EW; Ogden JA
Neurotoxicology; 2000 Oct; 21(5):659-65. PubMed ID: 11130269
[TBL] [Abstract][Full Text] [Related]
10. Neurobehavioral study on the interactive effects of age and solvent exposure.
Kiesswetter E; Sietmann B; Zupanic M; Seeber A
Neurotoxicology; 2000 Oct; 21(5):685-95. PubMed ID: 11130272
[TBL] [Abstract][Full Text] [Related]
11. [Intelligence, memory and malingering: correlation between scales].
Ramírez RM; Chirivella-Garrido J; Caballero MC; Ferri-Campos J; Noé-Sebastián E
Rev Neurol; 2004 Jan 1-15; 38(1):28-33. PubMed ID: 14730487
[TBL] [Abstract][Full Text] [Related]
12. Validation of symptom validity tests using a "child-model" of adult cognitive impairments.
Rienstra A; Spaan PE; Schmand B
Arch Clin Neuropsychol; 2010 Aug; 25(5):371-82. PubMed ID: 20484327
[TBL] [Abstract][Full Text] [Related]
13. The Test of Memory Malingering (TOMM): normative data from cognitively intact, cognitively impaired, and elderly patients with dementia.
Teichner G; Wagner MT
Arch Clin Neuropsychol; 2004 Apr; 19(3):455-64. PubMed ID: 15033228
[TBL] [Abstract][Full Text] [Related]
14. Performance profiles and cut-off scores on the Memory Assessment Scales.
O'Bryant SE; Duff K; Fisher J; McCaffrey RJ
Arch Clin Neuropsychol; 2004 Jun; 19(4):489-96. PubMed ID: 15163450
[TBL] [Abstract][Full Text] [Related]
15. Trail making test in chronic toxic encephalopathy: performance and discriminative potential.
Nilson L; Barregård L; Bäckman L
Clin Neuropsychol; 1999 Aug; 13(3):314-27. PubMed ID: 10726603
[TBL] [Abstract][Full Text] [Related]
16. Symptoms of chronic solvent encephalopathy: Euroquest questionnaire study.
Kaukiainen A; Hyvärinen HK; Akila R; Sainio M
Neurotoxicology; 2009 Nov; 30(6):1187-94. PubMed ID: 19963103
[TBL] [Abstract][Full Text] [Related]
17. [Inclusion of psychopathologic methods for diagnosis of early neurotoxic effects from lead and organic solvent mixtures].
Pfister E; Böckelmann I; Darius S; Wurthmann C
Fortschr Neurol Psychiatr; 1999 Oct; 67(10):435-40. PubMed ID: 10596364
[TBL] [Abstract][Full Text] [Related]
18. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
19. Establishing stable test performance in tests from the Behavioral Assessment and Research System (BARS).
Rohlman DS; Bailey SR; Brown M; Blanock M; Anger WK; McCauley L
Neurotoxicology; 2000 Oct; 21(5):715-23. PubMed ID: 11130275
[TBL] [Abstract][Full Text] [Related]
20. Use of Trial 1 of the Test of Memory Malingering (TOMM) as a screening measure of effort: suggested discontinuation rules.
Hilsabeck RC; Gordon SN; Hietpas-Wilson T; Zartman AL
Clin Neuropsychol; 2011 Oct; 25(7):1228-38. PubMed ID: 21846261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
